Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-21-019640
Filing Date
2021-01-28
Accepted
2021-01-27 21:54:00
Documents
7
Period of Report
2021-03-18

Document Format Files

Seq Description Document Type Size
1 DEF 14A d76219ddef14a.htm DEF 14A 1105930
2 GRAPHIC g76219g01r22.jpg GRAPHIC 199632
3 GRAPHIC g76219g03z11.jpg GRAPHIC 94914
4 GRAPHIC g76219g08m78.jpg GRAPHIC 50524
5 GRAPHIC g76219g20a36.jpg GRAPHIC 36588
6 GRAPHIC g76219g27e04.jpg GRAPHIC 54665
7 GRAPHIC g76219g70d20.jpg GRAPHIC 68095
  Complete submission text file 0001193125-21-019640.txt   1802666
Mailing Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105
Business Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105 626-696-4702
ARROWHEAD PHARMACEUTICALS, INC. (Filer) CIK: 0000879407 (see all company filings)

EIN.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: DEF 14A | Act: 34 | File No.: 001-38042 | Film No.: 21561860
SIC: 2834 Pharmaceutical Preparations